Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC15811 Nigericin sodium salt

    尼日利亚菌素钠盐

    尼杆菌素钠盐是一种来自湿地链霉菌的电中性K+/H+离子载体,它是一种亲脂性抗生素,可以选择性地导致钾从线粒体膜中流失。
  3. GC17532 Pertussis Toxin

    百日咳毒素

    百日咳毒素是一种基于蛋白质的 AB5 型外毒素,由百日咳博德特氏菌产生,可引起百日咳。

  4. GC17309 Withaferin A

    醉茄素A

    Withaferin A是一种甾体内酯,通常从冬虫夏草(Withania somnifera (L.) Dunal)中提取。
  5. GC13292 EGTA

    乙二醇双(2-氨基乙基醚)四乙酸

    A chelating agent
  6. GC17574 BAPTA

    1,2-双(2-氨基苯氧基)-乙烷-N,N,N`,N`-四乙酸

    An extracellular calcium chelator
  7. GC16795 DCA

    二氯乙酸钠

    DCA 是癌细胞中的代谢调节剂';具有抗癌活性的线粒体。 DCA 抑制 PDHK,导致肿瘤微环境中的乳酸减少。 DCA 增加活性氧 (ROS) 生成并促进癌细胞凋亡。 DCA 也可作为 NKCC 抑制剂。
  8. GC11664 YM 90709

    5,6-二氢-2,3-二甲氧基-6,6-二甲基苯并[7,8]吲哚嗪并[2,3-B]喹喔啉

    An IL-5 receptor antagonist
  9. GC16832 Suramin hexasodium salt

    苏拉明钠; Suramin hexasodium salt

    苏拉明六钠盐是一种具有多种生物活性的多磺化萘脲。
  10. GC12567 TRIM

    1-(2-三氟甲基苯基)咪唑

    An inhibitor of nNOS and iNOS
  11. GC16831 Agmatine sulfate

    胍基丁胺;硫酸胍基丁胺;硫酸鲱精胺;胍基丁胺硫酸盐

    A polyamine metabolite
  12. GC15727 Aminoguanidine hydrochloride

    氨基胍盐酸盐; Pimagedine hydrochloride; GER-11; Aminoguanidinium chloride

    An iNOS inhibitor
  13. GC13575 Pyrrolidinedithiocarbamate ammonium

    吡咯烷二硫代氨基甲酸铵; Ammonium pyrrolidinedithiocarbamate; PDTC ammonium; APDC

    A potent and reversible NF-κB inhibitor with antioxidant properties
  14. GC16656 L-Canavanine sulfate

    L-刀豆氨酸硫酸盐

    L-Canavanine硫酸盐是诱导型NO合酶的选择性抑制剂。
  15. GC12309 7-Nitroindazole

    7-硝基吲唑

    A non-selective inhibitor of NOS isoforms
  16. GC14851 Vidofludimus

    维多氟拉迪莫,4sc-101; SC12267

    An immunosuppressive drug that inhibits DHODH
  17. GC13926 BMS-345541(free base) BMS-345541(free base) 是 IKK 催化亚基的选择性抑制剂 (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM)。 BMS-345541(游离碱)结合在 IKK 的变构位点。
  18. GC15586 AP1903

    AP1903

    A CID for FKBPF36V fusion proteins
  19. GC16368 Indole-3-carbinol

    3-吲哚甲醇; I3C; 3-Indolemethanol

    A natural phytochemical
  20. GC17995 Tacrolimus monohydrate

    他克莫司一水合物; FK506 monohydrate; Fujimycin monohydrate; FR900506 monohydrate

    他克莫司一水合物 (FK506 monohydrate) 是一种大环内酯,与 FK506 结合蛋白 (FKBP) 结合形成复合物并抑制钙调神经磷酸酶,从而抑制 T 淋巴细胞信号转导和 IL-2 转录。
  21. GC13693 Omaveloxolone (RTA-408)

    RTA 408

    A synthetic triterpenoid that blocks Keap1/Nrf2 signaling
  22. GC11660 Nitisinone

    尼替西农; NTBC; Nitisone; SC0735

    An HPPD inhibitor
  23. GC11513 Zofenopril calcium

    佐芬普利钙,SQ26991

    A prodrug form of zofenoprilat
  24. GC18126 Balsalazide

    巴柳氮

    A prodrug form of 5-ASA
  25. GC16306 Dapsone

    氨苯砜; 4,4′-Diaminodiphenyl sulfone; DDS

    An anti-inflammatory, antimalarial, and antibacterial compound
  26. GC10210 VGX-1027

    GIT 27

    An immunomodulatory compound
  27. GC13066 Y-320 An inhibitor of IL-15-mediated CD4 T cell activation
  28. GC10451 U-73122

    1-[6-[((17Β)-3-雌酮-1,3,5[10]-三烯-17-基)氨基]乙基]-1H-吡咯-2,5-二酮

    U-73122是有效的、选择性的磷脂酶C(PLC)抑制剂,IC50值约为1-2.1µM,也可抑制5-脂氧合酶(5-LO)。
  29. GC18046 Erdosteine

    厄多司坦; RV 144

    A mucolytic agent and an antioxidant
  30. GC11702 DL-Carnitine HCl

    混旋肉碱盐酸盐,DL-Carnitine chloride

    DL-Carnitine HCl 存在两种异构体,称为 D 和 L。
  31. GC15550 Lacidipine

    拉西地平

    An L-type calcium channel blocker
  32. GC14586 Efaproxiral Sodium

    乙丙昔罗钠,RSR13 sodium

    An allosteric hemoglobin modifier
  33. GC15320 Diacerein

    双醋瑞因; Diacerhein; Diacetylrhein

    A prodrug form of rhein
  34. GC11670 Pranoprofen

    普拉洛芬

    An NSAID and COX-1 inhibitor
  35. GC16921 Bromhexine HCl

    盐酸溴己新

    Bromhexine HCl 是一种有效且特异性的 TMPRSS2 蛋白酶抑制剂,IC50 为 0.75 μM。
  36. GC11698 Valaciclovir HCl

    盐酸伐昔洛韦; Valaciclovir hydrochloride

    A prodrug of acyclovir
  37. GC13616 Sodium ascorbate

    维生素C钠; Sodium ascorbate; Sodium L-ascorbate; Vitamin C sodium salt

    抗坏血酸钠(Sodium L-ascorbate)是一种电子供体,是一种内源性抗氧化剂。抗坏血酸钠选择性抑制 Cav3.2 通道,IC50 为 6.5 μM.抗坏血酸钠也是一种胶原蛋白沉积增强剂和弹性生成抑制剂。
  38. GC10933 Sodium 4-Aminosalicylate

    对氨基水杨酸钠; 4-Aminosalicylic acid sodium salt dihydrate

    4-氨基水杨酸钠(4-氨基水杨酸钠盐二水合物)是目前用于耐多药结核病的抗分枝杆菌药物之一。
  39. GC12517 Sasapyrine

    双水杨酸酯; Salicylsalicylic acid; Disalicylic acid

    An NSAID and a prodrug form of salicylic acid
  40. GC17393 Pyridoxine HCl

    吡哆醇盐酸盐; Pyridoxol hydrochloride; Vitamin B6 hydrochloride

    A 4-methanol form of vitamin B6
  41. GC12114 Oxaprozin

    奥沙普秦; Oxaprozinum; Wy21743

    An NSAID and COX inhibitor
  42. GC16641 ML130 (Nodinitib-1)

    ML130; CID-1088438

    A selective NOD1 inhibitor
  43. GC16007 Methylthiouracil

    甲硫氧嘧啶; MTU

    甲基硫氧嘧啶是一种抗甲状腺药物。
  44. GC17830 IMD 0354

    N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺,IKK2 Inhibitor V

    An IKKβ (IKK2) inhibitor
  45. GC14622 Diclofenac Potassium

    双氯芬酸钾

    双氯芬酸钾是一种有效的非选择性抗炎剂,作为 COX 抑制剂,对人 COX-1 和 COX-2 在 CHO 细胞中的 IC50 分别为 4 和 1.3 nM ,对羊 COX- 的 IC50 分别为 5.1 和 0.84 μM。 1 和 COX-2,分别。
  46. GC13502 Cysteamine HCl

    半胱胺盐酸盐; 2-Aminoethanethiol hydrochloride; 2-Mercaptoethylamine hydrochloride

    A radioprotective aminothiol
  47. GC15058 Benzydamine HCl

    盐酸苄达明

    An Analytical Reference Standard
  48. GC11707 L-Ascorbyl 6-palmitate

    抗坏血酸棕榈酸酯; L-Ascorbic acid 6-hexadecanoate; 6-O-Palmitoyl-L-ascorbic acid

    A lipophilic derivative of ascorbic acid with antioxidant and antiproliferative activities
  49. GC11443 Allylthiourea

    烯丙基硫脲; Thiosinamine; N-Allylthiourea

    烯丙基硫脲是一种选择性抑制氨氧化的代谢抑制剂。
  50. GC14438 Suprofen

    舒洛芬; TN-762

    A non-selective NSAID
  51. GC12645 Imiquimod maleate

    马来酸咪喹莫特; R 837 maleate

    A TLR7 agonist

Items 4001 to 4050 of 4267 total

per page

Set Descending Direction